| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 463,175 | 315,676 | 401,901 | 441,459 | | Cost of Revenue | 261,348 | 210,377 | 235,374 | 265,671 | | | Gross Profit | 201,827 | 105,299 | 166,527 | 175,788 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 118,579 | 106,093 | 111,893 | 119,596 | | Non Recurring | 307 | 315 | 1,099 | 5,410 | | Others | 18,170 | 17,564 | 17,524 | 18,258 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 64,771 | (18,673) | 36,011 | 32,524 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (827) | 94 | (502) | | Earnings Before Interest And Taxes | 60,254 | (19,500) | 36,105 | 32,022 | | Interest Expense | (3,997) | 635 | 3,362 | 1,634 | | Income Before Tax | 64,251 | (20,135) | 32,743 | 30,388 | | Income Tax Expense | 26,079 | (12,906) | 9,002 | 7,057 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 38,172 | (7,229) | 23,741 | 23,331 | | | Non-recurring Events | | Discontinued Operations | (389) | 178 | (229) | 15,453 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 37,783 | (7,051) | 23,512 | 38,784 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $37,783 | ($7,051) | $23,512 | $38,784 |
|
0.31% Nasdaq 
0.05%
Income Statement
